Intuitive Surgical (NASDAQ:ISRG) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a hold rating to a buy rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.

A number of other research firms also recently commented on ISRG. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Wells Fargo & Company restated an “overweight” rating and issued a $487.00 price objective (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Finally, Leerink Partners cut their target price on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Stock Up 2.4%

Shares of ISRG opened at $377.94 on Friday. The stock has a 50 day moving average price of $375.18 and a 200 day moving average price of $422.52. The company has a market capitalization of $133.52 billion, a price-to-earnings ratio of 43.29, a price-to-earnings-growth ratio of 2.79 and a beta of 1.47. Intuitive Surgical has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.81 earnings per share. On average, equities analysts anticipate that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of Intuitive Surgical stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the completion of the transaction, the director owned 179 shares in the company, valued at approximately $70,364.90. This represents a 28.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 11,281 shares of company stock worth $4,484,224 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Dana Investment Advisors Inc. boosted its position in Intuitive Surgical by 1.9% in the 4th quarter. Dana Investment Advisors Inc. now owns 1,140 shares of the medical equipment provider’s stock valued at $646,000 after buying an additional 21 shares during the last quarter. Forefront Wealth Partners LLC increased its position in shares of Intuitive Surgical by 2.6% during the fourth quarter. Forefront Wealth Partners LLC now owns 819 shares of the medical equipment provider’s stock worth $464,000 after acquiring an additional 21 shares during the last quarter. High Note Wealth LLC lifted its stake in shares of Intuitive Surgical by 50.0% in the fourth quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 23 shares in the last quarter. White Lighthouse Investment Management Inc. lifted its stake in shares of Intuitive Surgical by 5.1% in the fourth quarter. White Lighthouse Investment Management Inc. now owns 473 shares of the medical equipment provider’s stock worth $268,000 after acquiring an additional 23 shares in the last quarter. Finally, Alteri Wealth LLC boosted its holdings in Intuitive Surgical by 5.0% in the fourth quarter. Alteri Wealth LLC now owns 483 shares of the medical equipment provider’s stock valued at $274,000 after purchasing an additional 23 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.